Skip to content
Home/Companies/Healthcare/Orakl Oncology
OO

Orakl Oncology

Healthcare·France·Active·2yr hold

Orakl Oncology is a healthcare company, headquartered in France.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Orakl Oncology?

Orakl Oncology is currently owned by Singular Capital Partners through Singular Ventures II (2023 vintage), since 2024. Across its history, Orakl Oncology has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Singular Capital Partners
Most recent investor
Singular Capital Partners
Singular Ventures II · 2023 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by SISTAFUND and Singular Capital Partners since 2023.
Co-invest · 2 holders · 2023 · present
SISTAFUND
SISTAFUNDActive
2023 · present · SISTA Fund I · 2022 · VC
MOIC
–
Singular Capital Partners
Singular Capital PartnersActive
2024 · present · Singular Ventures II · 2023 · VC
MOIC
–

More from Singular Ventures II

Other portfolio companies in the same fund.

Apoha
Active
HealthcareUK· 2026
Lucis
Active
HealthcareFrance· 2026
Lupa
Active
HealthcareUK· 2025
Manual
Active
HealthcareUK· 2025
Orus
Active
FinancialsFrance· 2025
Peec AI
Active
SoftwareGermany· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings